V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007904 | 310005076 | 1.74 | 83 | Adjuvant (A) | 2011-12-28 | 2013-06-21 | Abiraterone | 02 | N | 310019974 | VEMURAFENIB |
| 310007905 | 310005077 | 1.72 | 81 | Palliative (P) | null | 2014-08-29 | Pazopanib | 02 | N | 310019978 | ALEMTUZUMAB |
| 310007906 | 310005079 | null | 80 | Palliative (P) | 2016-03-05 | 2016-08-29 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 02 | N | 310019989 | DOXORUBICIN |
| 310007907 | 310005080 | 1.76 | 24.3 | Palliative (P) | 2017-04-04 | 2017-04-07 | CARBOPLATIN + RT | 2 | N | 310019990 | BORTEZOMIB |
| 310007908 | 310005080 | null | 117 | Palliative (P) | 2018-09-16 | 2018-09-16 | Methotrexate + Folinic acid | N | N | 310019990 | CAPECITABINE |
| 310007909 | 310008220 | 1.64 | 12.4 | Palliative (P) | 2015-06-12 | 2015-06-12 | ECX | 02 | null | 310019995 | OXALIPLATIN + MDG |
| 310007910 | 310005084 | 0 | 69.2 | Palliative (P) | 2017-05-28 | 2017-06-01 | CHLORAMBUCIL + DEXAMETHASONE + DEXAMETHASONE + ETOPOSIDE | 2 | N | 310019996 | TRABECTEDIN |
| 310007911 | 310005085 | 1.76 | null | Curative (C) | 2017-10-30 | 2018-01-27 | Capecitabine | 02 | N | 310019997 | OXALIPLATIN + MDG |
| 310007912 | 310008221 | 1.55 | 45.8 | null | 2017-09-02 | 2017-09-02 | LANREOTIDE | N | N | 310019998 | ERIBULIN |
| 310007913 | 310008221 | 1.7 | 67 | Palliative (P) | null | 2018-03-15 | CISPLATIN + ETOPOSIDE | null | null | 310019998 | MITOMYCIN |
| 310007914 | 310005087 | null | 92.2 | Palliative (P) | 2015-08-23 | 2015-09-07 | Trabectedin | N | null | 310020003 | METHOTREXATE |
| 310007915 | 310005087 | 1.67 | null | Palliative (P) | 2018-07-08 | 2018-07-09 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 310020003 | ERLOTINIB |
| 310007916 | 310005087 | 0 | 78.6 | Curative (C) | 2014-11-20 | 2015-03-14 | Bortezomib +/- Dexamethasone | 02 | N | 310020003 | CHOEP |
| 310007917 | 310011838 | null | 85 | Curative (C) | 2016-04-14 | 2017-06-04 | BCG Intravesical | N | N | 310020008 | DHAP - R |
| 310007918 | 310011931 | 1.71 | 87.2 | Adjuvant (A) | 2013-08-05 | 2013-08-05 | DABRAFENIB + TRAMETINIB | N | N | 310020015 | CETUXIMAB |
| 310007919 | 310011931 | 1.6 | 61.5 | Palliative (P) | 2017-02-14 | 2017-02-15 | VEDex | 02 | N | 310020015 | ATEZOLIZUMAB |
| 310007920 | 310005088 | 1.73 | null | Palliative (P) | 2015-10-17 | 2015-10-17 | CVD | 02 | N | 310020025 | DOXORUBICIN + GEMCITABINE |
| 310007921 | 310005089 | 1.78 | null | Palliative (P) | 2014-06-12 | 2014-06-14 | Cetuximab 7 day (Cycle 1) | N | N | 310020028 | TEMOZOLOMIDE |
| 310007922 | 310005089 | 0 | 73.5 | Adjuvant (A) | 2015-02-27 | 2015-04-16 | IBRUTINIB | null | null | 310020028 | TEMOZOLOMIDE |
| 310007923 | 310005090 | 1.85 | 68.9 | Palliative (P) | 2018-10-14 | 2018-11-21 | Cetuximab 7 day (Cycle 1) | N | N | 310020043 | CISPLATIN + DACARBAZINE |
| 310007924 | 310005091 | 1.56 | 60.2 | Palliative (P) | 2014-06-07 | 2014-06-08 | Triple / Double Intrathecal Therapy | 02 | N | 310020046 | GEMCITABINE + TREOSULPHAN |
| 310007925 | 310005092 | null | null | Curative (C) | 2016-04-17 | 2016-04-20 | Alemtuzumab (Subcutaneous) | N | N | 310020055 | TOPOTECAN |
| 310007926 | 310005092 | 1.57 | 78.4 | Palliative (P) | 2015-10-27 | 2015-11-01 | Bevacizumab+Carbo+Gemcitabine | N | N | 310020055 | CHLORAMBUCIL |
| 310007927 | 310005093 | null | null | Curative (C) | 2014-04-25 | 2014-04-25 | Vemurafenib | 2 | N | 310020060 | TEMOZOLOMIDE |
| 310007928 | 310005095 | 1.88 | 50 | Palliative (P) | 2017-06-27 | 2017-07-17 | METHOTREXATE | N | null | 310020061 | GEMCITABINE + OXALIPLATIN |
| 310007929 | 310008228 | 1.72 | 50 | Palliative (P) | null | 2017-11-19 | Vinblastine | N | N | 310020064 | TIP |
| 310007930 | 310005097 | 1.47 | 57.6 | Palliative (P) | 2017-07-26 | 2017-07-31 | Gemcitabine + Oxaliplatin | N | N | 310020066 | NIVOLUMAB |
| 310007931 | 310005098 | 1.7 | 70.75 | Palliative (P) | null | 2016-08-11 | Gemcitabine + Oxaliplatin | N | N | 310020066 | IVA |
| 310007933 | 310005100 | 1.83 | 111 | Palliative (P) | 2015-04-18 | 2015-04-27 | EP | N | N | 310020071 | ALEMTUZUMAB |
| 310007934 | 310009884 | 1.65 | 88 | Palliative (P) | 2016-08-09 | 2016-08-14 | EW EuroEwing 99 : VActC | null | N | 310020071 | CAPECITABINE + OXALIPLATIN |
| 310007935 | 310005102 | 1.63 | 56.7 | Adjuvant (A) | 2015-09-03 | 2015-09-03 | Mitoxantrone + Paclitaxel | 2 | N | 310020079 | TRABECTEDIN |
| 310007936 | 310005103 | 1.7 | 40.1 | Palliative (P) | 2017-09-29 | 2017-10-04 | Trabectedin | N | N | 310020087 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310007937 | 310009885 | 1.64 | 0 | Palliative (P) | 2014-05-30 | 2014-05-30 | Irinotecan + Modified De Gramont | 02 | null | 310020087 | IRINOTECAN + MDG |
| 310007938 | 310005105 | 0 | 78 | Curative (C) | 2015-09-29 | 2015-10-12 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 310020094 | GEMCITABINE + OXALIPLATIN |
| 310007939 | 310005105 | 1.81 | 69.6 | Palliative (P) | 2013-05-06 | 2013-05-12 | Temozolomide 200mg/m2 | N | N | 310020094 | PMITCEBO |
| 310007940 | 310011568 | 1.76 | 69 | Palliative (P) | 2015-09-02 | 2016-03-19 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 310020099 | CODOX M |
| 310007941 | 310011740 | 1.8 | null | Curative (C) | 2018-01-21 | 2018-01-22 | Dacarbazine | 1 | N | 310020104 | CTD |
| 310007942 | 310011740 | 1.57 | 99 | null | 2013-02-28 | 2013-02-28 | Oxaliplatin + Modified de Gramont | 02 | N | 310020104 | TEMOZOLOMIDE |
| 310007943 | 310005107 | 1.63 | 52.6 | Curative (C) | 2017-02-03 | 2017-02-17 | EOX | 2 | N | 310020108 | PEMETREXED |
| 310007944 | 310005108 | 1.81 | null | Palliative (P) | 2015-05-07 | 2015-05-09 | LENALIDOMIDE | 02 | N | 310020113 | CHLORAMBUCIL |
| 310007945 | 310005108 | null | 5.8 | Palliative (P) | 2017-12-16 | 2017-12-31 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | 310020113 | IVE-R |
| 310007946 | 310005108 | 1.65 | 10.7 | Palliative (P) | 2017-05-15 | 2017-05-20 | BEVACIZUMAB + CARBO | N | N | 310020113 | CAPECITABINE |
| 310007947 | 310005108 | 1.59 | 68.7 | Palliative (P) | 2015-06-27 | 2015-07-02 | Capecitabine + Oxaliplatin 21day | N | N | 310020113 | IRINOTECAN + MDG |
| 310007948 | 310011741 | 1.59 | 72 | Palliative (P) | 2015-10-04 | 2015-11-08 | Capecitabine | 02 | N | 310020119 | TOPOTECAN |
| 310007949 | 310011897 | 1.59 | null | Palliative (P) | 2015-08-20 | 2015-09-09 | FLUOROURACIL + OXALIPLATIN | N | N | 310020123 | IPILIMUMAB + NIVOLUMAB |
| 310007950 | 310005110 | 1.84 | 79.4 | Palliative (P) | 2016-11-04 | 2016-11-08 | Bendamustine + prednisolone | N | N | 310020124 | FLAG + IDARUBICIN |
| 310007951 | 310005111 | 1.47 | 54.7 | Curative (C) | 2014-03-03 | 2014-03-13 | Temozolomide 200mg/m2 | 02 | N | 310020124 | CAPECITABINE + CISPLATIN |
| 310007952 | 310011570 | null | 49.8 | Palliative (P) | 2016-01-15 | 2016-03-04 | IPILIMUMAB + NIVOLUMAB | null | N | 310020132 | EOX |
| 310007953 | 310005112 | 1.49 | 49.8 | Palliative (P) | 2013-09-28 | 2013-10-31 | Topotecan IV 7 day | N | N | 310020139 | ERIBULIN |
| 310007954 | 310005113 | 1.7 | 77 | Palliative (P) | 2015-09-04 | 2015-09-05 | CVP | N | N | 310020144 | CARBO + FLUOROURACIL |